期刊文献+

麝香保心丸治疗高血压合并冠心病临床效果研究 被引量:5

Study on Clinical Effect of Shexiangbaoxin Pills on Hypertension Complicated with Coronary Heart Disease
下载PDF
导出
摘要 目的:探讨麝香保心丸治疗高血压合并冠心病临床效果。方法:选取2017年4月~2019年4月收治的82例高血压合并冠心病患者为研究对象,采用黄蓝双色球法将其分为对照组和观察组,各41例。对照组采用常规西医治疗,观察组在此基础上采用麝香保心丸治疗,比较两组患者治疗前后血压变化情况和疗效。结果:治疗前,两组收缩压、舒张压比较,差异无统计学意义(P>0.05);治疗后,观察组收缩压(123.94±4.28)mmHg和舒张压(81.75±3.16)mmHg低于对照组的(132.47±3.62)mmHg和(87.39±2.14)mmHg,差异有统计学意义(P<0.05);观察组治疗总有效率为90.24%,高于对照组的73.17%,差异有统计学意义(P<0.05)。结论:在常规西医治疗基础上采用麝香保心丸治疗高血压合并冠心病能够有效降低患者血压水平,提升疗效。
作者 陈高祥 CHEN Gao-xiang
出处 《实用中西医结合临床》 2020年第13期125-126,共2页 Practical Clinical Journal of Integrated Traditional Chinese and Western Medicine
  • 相关文献

参考文献10

二级参考文献72

  • 1吴海霞,王成全,冯雪影,等.麝香保心丸联合曲美他嗪对冠心病心力衰竭患者血浆脑钠素的影响[J].中国药物经济学,2014,9(2):241.242.
  • 2Ana SR, Slavica Radovanovic, Tatjana P, et al. The role of serum VCAM-1 and TNF-a as predictors of mortality and morbidity in patients with chronic heart failure[J]. J Clin Lab Anal, 2013,27 (2) :213-217.
  • 3Cappuzzello C,Di Vito L, Melchionna R, et al. Increase of plasma IL-9 and decrease of plasma IL-5, IL-7, and IFN-7 in patients with chronic heart failure[J].Journal of Translational Medicine, 2011, 9(1): 28-33.
  • 4Olsen V, Rohde LE, Beck-da-Silva L, et al. QRS widening rates and genetic polymorphisms of matrix metalloproteinases in a cohort of patients with chronic heart failure[J]. The Canadian Journal of Cardiology, 2014,30 (3) : 345-351.
  • 5Christian Z,Peter M. Ivabradine treatment in a chronic heart fail- ure patient cohort: symptom reduction and improvement in quality of life in clinical practice[J]. Advances in Therapy, 2014,31(9): 961-974.
  • 6Stephen AH, Ronald AB, Lina S, et al. Use of BNP and NT-proB- NP for the diagnosis of heart failure in the emergency depart- ment:a systematic review of the evidence[J]. Heart Failure Re- views,2014,19(4) :421-438.
  • 7Saunders J T, Nambi V, de Lemos J A, et al. Cardiac tro-ponin T measured by a highly sensitive assay predicts coro-nary heart disease, heart failure and mortality in the athero-sclerosis risk in communities study [ J ]. Circulation, 2011,123(13) : 1367-1376.
  • 8Helgadottir A, Gretarsdottir S, Thorleifsson G, et al. Apoli-poprotein ( a) genetic sequence variants associated with sys-temic atherosclerosis and coronary atherosclerotic burden butnot with venous thromboembolism [ J ]. Journal of the Ameri-can College of Cardiology,2012,60(8) :722-729.
  • 9Roger VL, Go AS, Lloyd-Jones DM, et al. Heart disease and stroke statistics 2011 update: a report from the American Heart Association[J].Circulation, 2011, 123(4): elS-e209. DOI: 10.1161/CIR.0b013e3182009701.
  • 10郭朝阳.血清胆红素、丙二醛和尿酸联合检验在冠心病诊断中的意义[J].中国老年学杂志,2008,28(17):1740-1741. 被引量:5

共引文献120

同被引文献108

引证文献5

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部